Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0016 Transporter Info
Gene Name ABCC5
Transporter Name Multidrug resistance-associated protein 5
Gene ID
10057
UniProt ID
O15440
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Probenecid

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Probenecid inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 70 microM) [1]

Affected Drug/Substrate

 5-Fluorodeoxyuridine monophosphate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 2

 Probenecid inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 200 microM) [3]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 3

 Probenecid inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 34 microM) [4]

Affected Drug/Substrate

 Carboxydichlorofluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 4

 Probenecid inhibits the activity of ABCC5 [4]

  Sildenafil

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sildenafil inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 580 microM) [1]

Affected Drug/Substrate

 5-Fluorodeoxyuridine monophosphate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 2

 Sildenafil inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 80 microM) [3]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 3

 Sildenafil inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 (Ki = 0.267 microM) [5]

Affected Drug/Substrate

 Cyclic guanosine monophosphate Modulation Type Inhibition

Cell System

 Chinese hamster lung fibroblasts V79 cells (V79)-MRP5

  DT Modulation 4

 Sildenafil inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 [6]

Affected Drug/Substrate

 Cyclic guanosine monophosphate Modulation Type Inhibition

  Pemetrexed

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pemetrexed inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 2110 microM) [1]

Affected Drug/Substrate

 5-Fluorodeoxyuridine monophosphate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 2

 Pemetrexed inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 442 microM) [4]

Affected Drug/Substrate

 Carboxydichlorofluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 3

 Pemetrexed inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (Ki = 300 microM) [4]

Affected Drug/Substrate

 Carboxydichlorofluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  Methotrexate

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methotrexate inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 780 microM) [1]

Affected Drug/Substrate

 5-Fluorodeoxyuridine monophosphate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 2

 Methotrexate inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (Ki = 1059 microM) [4]

Affected Drug/Substrate

 Carboxydichlorofluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  Dipyridamole

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dipyridamole inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 30 microM) [3]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 2

 Dipyridamole inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 [6]

Affected Drug/Substrate

 Cyclic guanosine monophosphate Modulation Type Inhibition

  Sulfinpyrazone

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulfinpyrazone inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 300 microM) [3]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 2

 Sulfinpyrazone inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 103.2 microM) [4]

Affected Drug/Substrate

 Carboxydichlorofluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  Glyburide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glibenclamide inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 15 microM) [1]

Affected Drug/Substrate

 5-Fluorodeoxyuridine monophosphate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  Benzbromarone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzbromarone inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 150 microM) [3]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  Floxuridine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Floxuridine inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (Ki = 1163 microM) [4]

Affected Drug/Substrate

 Carboxydichlorofluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  Cisplatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cisplatin induces the activity of ABCC5 [7]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP5

  Rifampicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifampicin induces the activity of ABCC5 [7]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP5

  Fulvestrant

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fulvestrant inhibits the expression of ABCC5 [9]

  Acetaminophen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acetaminophen increases the expression of ABCC5 [10]

  Celecoxib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Celecoxib increases the expression of ABCC5 [11]

  Rifampin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifampin increases the expression of ABCC5 [12]

  Decitabine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Decitabine increases the expression of ABCC5 [13]

  Arsenic Trioxide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Arsenic Trioxide increases the expression of ABCC5 [14]

  Paclitaxel

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Paclitaxel increases the expression of ABCC5 [15]

  Hydrogen Peroxide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Hydrogen Peroxide affects the expression of ABCC5 [16]

  Aspirin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aspirin increases the expression of ABCC5 [17]

  Valproic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valproic Acid increases the expression of ABCC5 [18]

  Zoledronic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zoledronic Acid inhibits the expression of ABCC5 [19]

  Urethane

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Urethane increases the expression of ABCC5 [20]

  Sunitinib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sunitinib increases the expression of ABCC5 [21]

  Estradiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Estradiol inhibits the expression of ABCC5 [23]

  Zidovudine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zidovudine increases the expression of ABCC5 [24]

  Gemcitabine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gemcitabine induces the activity of ABCC5 [25]

  Fluorouracil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fluorouracil induces the activity of ABCC5 [25] , [26]

  Micafungin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Micafungin inhibits the activity of ABCC5 [27]

Drug Marketed but not Approved by US FDA

  Rotenone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rotenone inhibits the expression of ABCC5 [22]

Drug in Phase 3 Trial

  Curcumin

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Curcumin inhibits the transportation of 5-Fluorouracil by ABCC5 (IC50 = 0.5 +/- 0.1 microM) [2]

Affected Drug/Substrate

 5-Fluorouracil Modulation Type Inhibition

Cell System

 Human pancreatic cancer cell lines (PANC-1)-MRP5

  DT Modulation 2

 Curcumin inhibits the transportation of 5-Fluorouracil by ABCC5 (IC50 = 0.7 +/- 0.1 microM) [2]

Affected Drug/Substrate

 5-Fluorouracil Modulation Type Inhibition

Cell System

 MiaPaCa-2 pancreatic cancer cells

  DT Modulation 3

 Curcumin inhibits the transportation of 5-Fluorouracil by ABCC5 (IC50 = 20.1 +/- 2.2 microM) [2]

Affected Drug/Substrate

 5-Fluorouracil Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 4

 Curcumin inhibits the transportation of 2',7'-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein by ABCC5 [2]

Affected Drug/Substrate

 2',7'-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  Afimoxifene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Afimoxifene increases the expression of ABCC5 [9]

Drug in Phase 2 Trial

  Genistein

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Genistein inhibits the expression of ABCC5 [36]

  Bisphenol A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bisphenol A increases the expression of ABCC5 [39]

Drug in Phase 1 Trial

  Dihydrotestosterone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dihydrotestosterone affects the expression of ABCC5 [29]

  LY-294002

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 LY-294002 inhibits the expression of ABCC5 [33]

Drug in Preclinical Test

  (+)-JQ1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 (+)-JQ1 increases the expression of ABCC5 [35]

Discontinued Drug

  Trequinsin

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Trequinsin inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 580 microM) [1]

Affected Drug/Substrate

 5-Fluorodeoxyuridine monophosphate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 2

 Trequinsin inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 30 microM) [3]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 3

 Trequinsin inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 218 microM) [4]

Affected Drug/Substrate

 Carboxydichlorofluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 4

 Trequinsin inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 (Ki = 0.24 microM) [5]

Affected Drug/Substrate

 Cyclic guanosine monophosphate Modulation Type Inhibition

Cell System

 Chinese hamster lung fibroblasts V79 cells (V79)-MRP5

  Zaprinast

            4 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zaprinast inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 20 microM) [1]

Affected Drug/Substrate

 5-Fluorodeoxyuridine monophosphate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 2

 Zaprinast inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 250 microM) [3]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 3

 Zaprinast inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 32.3 microM) [4]

Affected Drug/Substrate

 Carboxydichlorofluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 4

 Zaprinast inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 [6]

Affected Drug/Substrate

 Cyclic guanosine monophosphate Modulation Type Inhibition

  MK-571

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 MK-571 inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 17 microM) [1]

Affected Drug/Substrate

 5-Fluorodeoxyuridine monophosphate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  DT Modulation 2

 MK-571 inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 200 microM) [3]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 3

 MK-571 inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 15.9 microM) [4]

Affected Drug/Substrate

 Carboxydichlorofluorescein Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

Investigative Drug

  Cyclic AMP

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyclic adenosine monophosphate inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 [5]

Affected Drug/Substrate

 Cyclic guanosine monophosphate Modulation Type Inhibition

Cell System

 Chinese hamster lung fibroblasts V79 cells (V79)-MRP5

  4-(2-Aminoethyl) benzenesulfonyl fluoride

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 4-(2-Aminoethyl) benzenesulfonyl fluoride inhibits the activity of ABCC5 [42]

Natural Product

  Plant polyphenols

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Plant polyphenols inhibits the activity of ABCC5 [8]

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  Silymarin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Silymarin inhibits the activity of ABCC5 [8]

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP5

  Particulate Matter

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Particulate Matter increases the expression of ABCC5 [34]

  Deguelin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Deguelin inhibits the expression of ABCC5 [22]

  Tobacco Smoke Pollution

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tobacco Smoke Pollution inhibits the expression of ABCC5 [41]

  Chrysin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chrysin inhibits the expression of ABCC5 [33]

Regulation Mechanism

 via the inhibition of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Affected Drug/Substrate

 Doxorubicin Modulation Type Inhibition

Cell System

 Human endocervical adenocarcinoma cells (BEL-7402)

Traditional Medicine

  Jinfukang

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Jinfukang increases the expression of ABCC5 [37]

Environmental toxicant

  Polychlorinated dibenzodioxin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Polychlorinated dibenzodioxin increases the expression of ABCC5 [28]

Regulation Mechanism

 via enhancement of Aryl hydrocarbon receptor (AHR) Transcription Factor Info

Cell System

 Human gastric signet ring cell adenocarcinoma cells (SNU-601)

Acute Toxic Substance

  Cycloheximide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cycloheximide inhibits the expression of ABCC5 [9]

  2-butenal

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-butenal inhibits the expression of ABCC5 [30]

  Formaldehyde

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Formaldehyde increases the expression of ABCC5 [32]

Carcinogen

  Benzo(a)pyrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzo(a)pyrene increases the expression of ABCC5 [31]

  Ethyl Methanesulfonate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ethyl Methanesulfonate increases the expression of ABCC5 [32]

Fungicide

  Azoxystrobin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Azoxystrobin inhibits the expression of ABCC5 [22]

Pesticide/Insecticide

  Dicrotophos

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dicrotophos increases the expression of ABCC5 [38]

Health and Environmental Toxicant

  Perfluorooctane sulfonic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Perfluorooctane sulfonic acid inhibits the expression of ABCC5 [40]
References
1 The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther. 2005 May;4(5):855-63.
2 Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Cancer Chemother Pharmacol. 2011 Sep;68(3):603-10.
3 Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol Pharmacol. 2003 May;63(5):1094-103.
4 Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport. Eur J Pharm Sci. 2006 Apr;27(5):524-32.
5 The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem. 2000 Sep 29;275(39):30069-74.
6 Novel cGMP efflux inhibitors identified by virtual ligand screening (VLS) and confirmed by experimental studies. J Med Chem. 2012 Apr 12;55(7):3049-57.
7 Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett. 2001 Mar 31;120(1-3):51-7.
8 Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J. 2005 Sep;272(18):4725-40.
9 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
10 Induction of hepatobiliary efflux transporters in acetaminophen-induced acute liver failure cases. Drug Metab Dispos. 2007 Oct;35(10):1963-9.
11 Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy. Curr Cancer Drug Targets. 2008 Aug;8(5):414-20.
12 Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem Pharmacol. 2009 Mar 1;77(5):897-909.
13 The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009 Feb;41(2):178-186.
14 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
15 Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head Neck. 2011 Jul;33(7):959-68.
16 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352.
17 Prolonged use of aspirin alters human and rat intestinal cells and thereby limits the absorption of clopidogrel. Clin Pharmacol Ther. 2011 Oct;90(4):612-9.
18 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
19 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
20 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
21 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761.
22 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615.
23 17 beta-Estradiol Activates HSF1 via MAPK Signaling in ER alpha-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533.
24 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23.
25 Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. Neoplasia. 2010 Sep;12(9):740-7.
26 Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil. Drug Metab Dispos. 2011 Jan;39(1):132-9.
27 Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP. Antimicrob Agents Chemother. 2016 May 23;60(6):3372-9.
28 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced cell-specific drug transporters with acquired cisplatin resistance in cisplatin sensitive cancer cells. J Korean Med Sci. 2014 Sep;29(9):1188-98.
29 Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells. Prostate Cancer Prostatic Dis. 2007;10(1):39-45.
30 Gene expression profile and cytotoxicity of human bronchial epithelial cells exposed to crotonaldehyde. Toxicol Lett. 2010 Aug 16;197(2):113-22.
31 Inter- and intra-laboratory study to determine the reproducibility of toxicogenomics datasets. Toxicology. 2011 Nov 28;290(1):50-8.
32 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
33 Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway. Chem Biol Interact. 2013 Oct 25;206(1):100-8.
34 Global gene expression profiling of human bronchial epithelial cells exposed to airborne fine particulate matter collected from Wuhan, China. Toxicol Lett. 2014 Jul 3;228(1):25-33.
35 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
36 Dose- and Time-Dependent Transcriptional Response of Ishikawa Cells Exposed to Genistein. Toxicol Sci. 2016 May;151(1):71-87.
37 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
38 Molecular mechanisms of discrotophos-induced toxicity in HepG2 cells: The role of CSA in oxidative stress. Food Chem Toxicol. 2017 May;103:253-260.
39 Bisphenolic compounds alter gene expression in MCF-7 cells through interaction with estrogen receptor alpha. Toxicol Appl Pharmacol. 2020 Jul 15;399:115030.
40 An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model. Environ Toxicol. 2020 Dec;35(12):1395-1405.
41 Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. Arch Toxicol. 2021 May;95(5):1739-1761.
42 Fluo-cAMP is transported by multidrug resistance-associated protein isoform 4 in rat choroid plexus. J Neurochem. 2010 Oct;115(1):200-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.